---
title: "Gemtuzumab Ozogamicin - Acute Myeloid Leukemia, Disease - 3"
sidebar: mydoc_sidebar
permalink: db00056-mesh-d015470-3.html
toc: false 
---


Path ID: `DB00056_MESH_D015470_3`
{% include image.html url="images/db00056-mesh-d015470-3.png" file="db00056-mesh-d015470-3.png" alt="db00056-mesh-d015470-3" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000079982 | Gemtuzumab ozogamicin | Drug |
| MESH:D000080084 | Calicheamicins | ChemicalSubstance |
| GO:0033028 | Myeloid cell apoptotic process | BiologicalProcess |
| UniProt:P20138 | Myeloid cell surface antigen CD33 | Protein |
| CL:0000763 | Myeloid cell | Cell |
| MESH:D015470 | Acute myeloid leukemia, disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Gemtuzumab Ozogamicin | HAS METABOLITE | Calicheamicins |
| Calicheamicins | POSITIVELY REGULATES | Myeloid Cell Apoptotic Process |
| Myeloid Cell Apoptotic Process | NEGATIVELY CORRELATED WITH | Acute Myeloid Leukemia, Disease |
| Gemtuzumab Ozogamicin | DECREASES ACTIVITY OF | Myeloid Cell Surface Antigen Cd33 |
| Myeloid Cell Surface Antigen Cd33 | EXPRESSED IN | Myeloid Cell |
| Myeloid Cell | AFFECTED BY | Acute Myeloid Leukemia, Disease |
|---------|-----------|---------|

Comment: Gemtuzumab ozogamicin is a monoclonal anti-CD33 antibody

Reference: 
  - [https://go.drugbank.com/drugs/DB00056](https://go.drugbank.com/drugs/DB00056)
  - [http://chemocare.com/chemotherapy/drug-info/gemtuzumab-ozogamicin.aspx](http://chemocare.com/chemotherapy/drug-info/gemtuzumab-ozogamicin.aspx)
